No connection

Search Results

Analysis Neutral

ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy Claims in Advertisement

Mar 31, 2026 15:06 UTC

ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy Claims in Advertisement.

Share this article

Related Articles

Score 35

JPMorgan Chase Targets Small‑Business Growth to Reinforce the American Dream

Mar 31, 17:46

Score 58

Iran Tightens Grip on Strategic Strait of Hormuz

Mar 31, 16:42

Score 12

Buffett Warns That an Iranian Nuclear Weapon Would Complicate Global Disaster Prevention

Mar 31, 16:38

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile